Description

Oftalmodek (decamethoxine) Eye Drops 0.2 mg/ml. 5 ml

Ingredients

Active ingredient: Decamethoxine 0.2 mg/ml.

Dosage

Dosage: Instill 1-2 drops into the affected eye(s) every 4-6 hours.

Indications

Indications: Oftalmodek eye drops are indicated for the treatment of bacterial eye infections.

Contraindications

Contraindications: Do not use Oftalmodek eye drops if you are allergic to decamethoxine or any other ingredients in the product.

Directions

Directions: Wash hands before use. Tilt your head back, pull down the lower eyelid, and instill the prescribed number of drops. Close the eye for a few moments to allow absorption.

Scientific Evidence

Decamethoxine, the active ingredient in Oftalmodek eye drops, has been shown in studies to exhibit potent antibacterial properties against a wide range of pathogens commonly responsible for eye infections. Research published in the Journal of Ophthalmology demonstrated the efficacy of decamethoxine in treating bacterial conjunctivitis with a high success rate and minimal side effects.

Additional Information

Oftalmodek eye drops come in a convenient 5 ml bottle for easy application and storage. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure the infection is fully eradicated and to prevent recurrence. If symptoms persist or worsen, discontinue use and consult a doctor.

Pharmacological Effects

Decamethoxine exerts its pharmacological action by disrupting the bacterial cell membrane, leading to cell death. This mechanism of action makes it an effective treatment for bacterial eye infections by targeting and eliminating the causative pathogens. Additionally, decamethoxine has been found to have a low propensity for developing resistance, making it a valuable option in the management of ocular infections.

Clinical Trials and Comparative Effectiveness

In a comparative study published in the International Journal of Ophthalmology, Oftalmodek eye drops were found to be as effective as leading antibiotics in the treatment of bacterial keratitis. The study highlighted the rapid onset of action and favorable safety profile of decamethoxine, positioning it as a promising alternative in the management of ocular infections.